The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma
Open accessAbstract
The cure rate of osteosarcoma has not improved in the past 30 years. The search for new treatments and drugs is urgently needed. Apatinib is a high selectivity inhibitor of vascular endothelial growth factor receptor-2 (VEGFR2) tyrosine kinase, exerting promising antitumoral effect in various tumors. The antitumor effect of Apatinib in human osteosarcoma has never been reported. We investigated the effects of Apatinib in osteosarcoma in vitro and in vivo. Osteosarcoma patients with high levels of VEGFR2 have poor prognosis. Apatinib can inhibit cell growth of osteosarcoma cells. In addition to cycle arrest and apoptosis, Apatinib induces autophagy. Interestingly, inhibition of autophagy increased Apatinib-induced apoptosis in osteosarcoma cells. Immunoprecipitation confirmed direct binding between VEGFR2 and signal transducer and activator of transcription 3 (STAT3). Downregulation of VEGFR2 by siRNA resulted in STAT3 inhibition in KHOS cells. VEGFR2 and STAT3 are inhibited by Apatinib in KHOS cells, and STAT3 act downstream of VEGFR2. STAT3 and BCL-2 were downregulated by Apatinib. STAT3 knockdown by siRNA reinforced autophagy and apoptosis induced by Apatinib. BCL-2 inhibits autophagy and was apoptosis restrained by Apatinib too. Overexpression of BCL-2 decreased Apatinib-induced apoptosis and autophagy. Apatinib repressed the expression of STAT3 and BCL-2 and suppressed the growth of osteosarcoma in vivo. To sum up, deactivation of VEGFR2/STAT3/BCL-2 signal pathway leads to Apatinib-induced growth inhibition of osteosarcoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wu, J. T., Zhang, J., Shen, B., Yin, K., Xu, J., Gao, W., & Zhang, L. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0229-3 · Cited by 117
RetractedRole of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
The Beclin 1 network regulates autophagy and apoptosis
Kang, R., Zeh, H. J., Lotze, M. T., & Tang, D. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.191 · Cited by 2,485
Life and death partners: apoptosis, autophagy and the cross-talk between them
Eisenberg-Lerner, A., Bialik, S., Simon, H.-U., & Kimchi, A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.33 · Cited by 1,183
Li, J., Qin, S., Xu, J., Xiong, J., Wu, C., Bai, Y., Liu, W., Tong, J., Liu, Y., Xu, R., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.5995 · Cited by 972
Buzzai, M., Jones, R. G., Amaravadi, R. K., Lum, J. J., DeBerardinis, R. J., Zhao, F., Viollet, B., & Thompson, C. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4447 · Cited by 923
Li, J., Qin, S., Xu, J., Guo, W., Xiong, J., Bai, Y., Sun, G., Yang, Y., Wang, L., Xu, N., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.8585 · Cited by 533
Self-citationCross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1
Djavaheri-Mergny, M., Maiuri, M. C., & Kroemer, G. (2010) · Oncogene · doi:10.1038/onc.2009.519 · Cited by 388
He, C., Zhu, H., Li, H., Zou, M.-H., & Xie, Z. (2013) · Diabetes · doi:10.2337/db12-0533 · Cited by 365
Shi, W.-Y., Xiao, D., Wang, L., Dong, L.-H., Yan, Z.-X., Shen, Z.-X., Chen, S.-J., Chen, Y., & Zhao, W.-L. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.13 · Cited by 308
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
Tomic, T., Botton, T., Cerezo, M., Robert, G., Luciano, F., Puissant, A., Gounon, P., Allegra, M., Bertolotto, C., Bereder, J.-M., et al. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.86 · Cited by 301
The multiple roles of autophagy in cancer
Rosenfeldt, M. T., & Ryan, K. M. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr031 · Cited by 300
Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer
Hasima, N., & Ozpolat, B. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.467 · Cited by 257
Akar, U., Chaves-Reyez, A., Barria, M., Tari, A., Sanguino, A., Kondo, Y., Kondo, S., Arun, B., Lopez-Berestein, G., & Ozpolat, B. (2008) · Autophagy · doi:10.4161/auto.6083 · Cited by 253
Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
Ando, K., Heymann, M.-F., Stresing, V., Mori, K., Rédini, F., & Heymann, D. (2013) · Cancers · doi:10.3390/cancers5020591 · Cited by 234
Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer
Hu, X., Cao, J., Hu, W., Wu, C., Pan, Y., Cai, L., Tong, Z., Wang, S., Li, J., Wang, Z., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-820 · Cited by 225
Self-citationDeng, X.-S., Wang, S., Deng, A., Liu, B., Edgerton, S. M., Lind, S. E., Wahdan-Alaswad, R., & Thor, A. D. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18813 · Cited by 213
Self-citationApatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma
Peng, H., Zhang, Q., Li, J., Zhang, N., Hua, Y., Xu, L., Deng, Y., Lai, J., Peng, Z., Peng, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7948 · Cited by 140
Osteosarcoma Multidisciplinary Approach to the Management from the Pathologist’s Perspective
Raymond, A. K., & Jaffe, N. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_4 · Cited by 125
Yang, J., & Yao, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025744 · Cited by 118
Gao, D., Lv, A., Li, H., Han, D., & Zhang, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25987 · Cited by 118
Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent
Morgan, M. J., Gamez, G., Menke, C., Hernandez, A. L., Thorburn, J., Gidan, F., Staskiewicz, L., Morgan, S. C., Cummings, C. T., Maycotte, P., et al. (2014) · Autophagy · doi:10.4161/auto.32135 · Cited by 105
Tang, Q., Li, G., Wei, X., Zhang, J., Chiu, J., Hasenmayer, D., Zhang, D., & Zhang, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.023 · Cited by 104
Sui, C., Zhou, Y., Shen, W.-F., Dai, B., Lu, J., Zhang, M.-F., & Yang, J. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1442-z · Cited by 101
Differential roles of STAT3 in the initiation and growth of lung cancer
Zhou, J., Qu, Z., Yan, S., Sun, F., Whitsett, J. A., Shapiro, S. D., & Xiao, G. (2014) · Oncogene · doi:10.1038/onc.2014.318 · Cited by 92
Wen, W. X., Liang, W. P., Wu, J., Kowolik, C. M., Buettner, R., Scuto, A., Hsieh, M.-Y., Hong, H., Brown, C. E., Forman, S. J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0077 · Cited by 88
Liu, Z., Gan, L., Zhou, Z., Jin, W., & Sun, C. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.02.004 · Cited by 87
Kopechek, J. A., Carson, A. R., McTiernan, C. F., Chen, X., Hasjim, B. J., Lavery, L., Sen, M., Grandis, J. R., & Villanueva, F. S. (2015) · Theranostics · doi:10.7150/thno.12822 · Cited by 77
Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells
Chen, X., Ying, Z., Lin, X., Lin, H., Wu, J., Li, M., & Song, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68143 · Cited by 75
Kim, S., Park, K.-Y., Yoon, W.-C., Park, S., Park, K., Yoo, D., & Choe, J. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.01.004 · Cited by 75
Yue, P., Lopez‐Tapia, F., Paladino, D., Li, Y., Chen, C., Namanja, A. T., Hilliard, T. S., Chen, Y., Tius, M. A., & Turkson, J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3558 · Cited by 74
Sevelda, F., Mayr, L., Kubista, B., Lötsch, D., van Schoonhoven, S., Windhager, R. H., Pirker, C., Micksche, M., & Berger, W. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0251-5 · Cited by 74
Sun, Y., Guo, W., Ren, T., Liang, W., Zhou, W., Lu, Q., Jiao, G., & Yan, T. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.497 · Cited by 69
Self-citationJakhar, R., Paul, S., Bhardwaj, M., & Kang, S. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.12.024 · Cited by 69
Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China
Li, F., Liao, Z., Zhao, J. L., Zhao, G., Li, X., Du, X., Yang, Y., & Yang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16293 · Cited by 61
Zhang, H.-F., Chen, Y., Wu, C., Wu, Z.-Y., Tweardy, D. J., Alshareef, A., Liao, L., Xue, Y.-J., Wu, J.-Y., Chen, B., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1253 · Cited by 57
Timme, S., Ihde, S., Fichter, C. D., Waehle, V., Bogatyreva, L., Atanasov, K., Kohler, I., Schöpflin, A., Geddert, H., Faller, G., et al. (2013) · Oncogene · doi:10.1038/onc.2013.298 · Cited by 54
PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway
Yang, Z., Liu, S., Zhu, M., Zhang, H., Wang, J., Xu, Q., Lin, K., Zhou, X., Tao, M., Li, C., et al. (2016) · Scientific Reports · doi:10.1038/srep22090 · Cited by 49
Oh, S.-B., Hwang, C. J., Song, S.-Y., Jung, Y. Y., Yun, H.-M., Sok, C. H., Sung, H. C., Yi, J.-M., Park, D. H., Ham, Y. W., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.007 · Cited by 41
Li, L., Lin, J., Sun, G., Wei, L., Shen, A., Zhang, M., & Peng, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5171 · Cited by 40
Bao, X., Ren, T., Huang, Y., Wang, S., Zhang, F., Liu, K., Zheng, B., & Guo, W. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0407-y · Cited by 22
Self-citation
Cited by
The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
Corre, I., Verrecchia, F., Crenn, V., Redini, F., & Trichet, V. (2020) · Cells · doi:10.3390/cells9040976 · Cited by 474
Xie, L., Xu, J., Sun, X., Tang, X., Yan, T., Yang, R., & Guo, W. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0542 · Cited by 128
Self-citationZheng, B., Ren, T., Huang, Y., & Guo, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.032 · Cited by 89
Xie, L., Xu, J., Sun, X., Li, X., Liu, K., Liang, X., Zhou, Z., Zhuang, H., Sun, K., Wu, Y., et al. (2021) · Oncology Letters · doi:10.3892/ol.2021.12813 · Cited by 19
Self-citation
Metadata
- Authors
- Liu, K., Ren, T., Huang, Y., Sun, K., Bao, X., Wang, S., Zheng, B., & Guo, W.
- Venue
- Cell Death & Disease
- Published
- 2017-08-24
- Volume
- 8
- Issue
- 8
- Pages
- e3015-e3015
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W2747989445
- Cited by
- 264
- References
- 41
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.